Ptc Therapeutics (PTCT) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to -$32.6 million.
- Ptc Therapeutics' Interest & Investment Income rose 2167.08% to -$32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$138.1 million, marking a year-over-year increase of 1886.28%. This contributed to the annual value of -$167.0 million for FY2024, which is 2927.16% down from last year.
- As of Q3 2025, Ptc Therapeutics' Interest & Investment Income stood at -$32.6 million, which was up 2167.08% from -$30.4 million recorded in Q2 2025.
- In the past 5 years, Ptc Therapeutics' Interest & Investment Income ranged from a high of -$19.2 million in Q1 2021 and a low of -$44.3 million during Q4 2023
- Over the past 5 years, Ptc Therapeutics' median Interest & Investment Income value was -$28.2 million (recorded in 2023), while the average stood at -$30.0 million.
- Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 31939.02% in 2021, then skyrocketed by 3019.54% in 2025.
- Over the past 5 years, Ptc Therapeutics' Interest & Investment Income (Quarter) stood at -$22.5 million in 2021, then fell by 8.88% to -$24.5 million in 2022, then crashed by 80.71% to -$44.3 million in 2023, then rose by 7.26% to -$41.1 million in 2024, then rose by 20.62% to -$32.6 million in 2025.
- Its Interest & Investment Income was -$32.6 million in Q3 2025, compared to -$30.4 million in Q2 2025 and -$34.1 million in Q1 2025.